Certmedica and XO Life: Collaboration enables digital therapy support for sustainable weight loss and control

Munich, Germany, August 14, 2024 — Certmedica, a leading company in the development, manufacturing and worldwide distribution of medical devices, and XO Life, a pioneering digital health startup, announce their collaboration in the spirit of advanced healthcare. With Formoline L112 and Formoline L112 EXTRA, Certmedica has the most recommended and millions of times used slimming product from Germany's pharmacies in its product portfolio. Users of active fiber L112 can now use XO Life's ImpactMonitor™ platform. The meta platform provides digital therapy support for treatment with the lipid binder (fat binder) and offers additional support in overweight treatment and weight management.

‍

According to Statista, millions of people in Germany want to lose weight. Diets and exercise programs alone do not always lead to the desired weight loss result. In cases of stubborn overweight or the yo-yo effect, the certified medical devices Formoline L112 and Formoline L112 EXTRA provide support for sustainable weight loss and control. The active fiber L112 from natural sources binds a large part of the absorbed dietary fats in the gastrointestinal tract and thus reduces calorie intake.

Digital support on the way to a healthy feel-good weight

To help users of Formoline L112 and Formoline L112 EXTRA on their way to a healthy and personal feel-good weight, they now have access to the Certmedica Formoline L112 product range on XO Life's ImpactMonitor™ platform after signing up for free. After logging in, the exclusive area offers Certmedica customers information specifically about the L112 medical device and other tips for losing weight. This optimally supplements the intake of active fiber. Users can continuously and measurably track their weight, compare treatment with others and make individual adjustments to achieve their goals. Through the information provided in digital treatment support, users also learn more about how the lipid binder works, which improves their understanding, increases motivation and can help them achieve their personal feel-good weight.

Impact Monitor™ platform: digital therapy support

“Formoline L112 and Formoline L112 EXTRA help people to reduce their weight healthily in order to achieve or maintain their comfortable weight. Thanks to the Impact Monitor™ platform, our customers now have an additional opportunity to closely track their progress and better understand the reasons behind the therapy. The user-friendly interface provides a clear, informative overview and helps you to successfully carry out the treatment and stay motivated,” says Dr. van Rensen, Head of Medicine and Communications at Certmedica.

Dr. Friderike Bruchmann, Co-Founder & CEO of XO Life, continues: “The collaboration between Certmedica and XO Life sets new standards for sustainable weight loss and helps to achieve weight loss goals. We are pleased to support Formoline L112 customers with free digital support on an issue as important for personal well-being as weight loss. ”

About Certmedica

Certmedica International GmbH is a medium-sized pharmaceutical company based in Aschaffenburg near Frankfurt am Main, which has been developing and marketing high-quality health products for over 20 years. The core competencies lie in the development and sale of high-quality medical products, dietary supplements and cosmetics in currently more than 40 countries in Europe and around the world.

As a manufacturer of high-quality medical devices, Certmedica International focuses particularly on the health and well-being of users of its products. In order to offer as many people as possible the opportunity to positively influence their own health with high-quality products, Certmedica International is taking on the challenge of ensuring the research, development and marketing of products from a single source.

The high quality standards and continuous innovative spirit are the basis for Certmedica International's leading position in the slimming products, dietetic and xerostomia segment, particularly in the German and Austrian pharmacy market.

Site: www.certmedica.com

LinkedIn: https://de.linkedin.com/company/certmedica-international-gmbh

DocCheck: https://www.doccheck.com/de/profile/channels/1030-ueber-gewicht-der-kanal-fuer-gesundes-koerpergewicht

Impact Monitor: https://formolinel112.impactmonitor.io/landingpage

‍

About XO Life

XO Life has created a globally unique meta-platform, the ImpactMonitor™ platform, for digital product and therapy support for patients. During their product use or therapy, patients are accompanied with verified medical and health-related content, record their health and treatment history, receive personalized insights and medical support from experts, and can exchange ideas with other patients.

Manufacturers can license their own product and therapy areas on the ImpactMonitor™ platform and make them available to their patients with their own branding, content, questions and services. Through personalized information and continuous support during therapies, manufacturers make an important contribution to treatment success, treatment adherence and application safety for patients.

XO Life is one of the biggest hopefuls in healthcare and is one of the leading digital health startups in Germany and Europe. In March 2023, XO Life was nominated as one of 10 startups from various sectors of the economy for the Digital Award by the Federal Ministry of Economics and Climate Protection. XO Life works with world market leaders, medium-sized German pharmaceutical companies and orphan drug manufacturers and is now offering the ImpactMonitor™ platform in all European countries and languages.

‍

Further links

Site: www.xo-life.com

LinkedIn: https://www.linkedin.com/company/xo-life

YouTube: https://www.youtube.com/@xo-life/featured

‍